Evidence map›Paper›PMID 42211562›Full record

ArticleTobacco prevention & cessation2026

From cool to non-cool: California's 'non-menthol' cigarettes in 2025.

Sairam V Jabba, Hanno C Erythropel, Paul T Anastas, Stephanie S O'Malley, Suchitra Krishnan-Sarin, Julie B Zimmerman, Sven E Jordt

Abstract readLetter
In one paragraph

Article in Tobacco prevention & cessation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sairam V Jabba *Department of Anesthesiology, Duke University School of Medicine, Durham, United States.
Hanno C Erythropel *Yale Tobacco Center of Regulatory Science, Department of Psychiatry, Yale School of Medicine, New Haven, United States.
Paul T AnastasCenter for Green Chemistry and Green Engineering, Yale School of the Environment, New Haven, United States.
Stephanie S O'MalleyYale Tobacco Center of Regulatory Science, Department of Psychiatry, Yale School of Medicine, New Haven, United States.
Suchitra Krishnan-SarinYale Tobacco Center of Regulatory Science, Department of Psychiatry, Yale School of Medicine, New Haven, United States.
Julie B ZimmermanYale Tobacco Center of Regulatory Science, Department of Psychiatry, Yale School of Medicine, New Haven, United States.
Sven E JordtDepartment of Anesthesiology, Duke University School of Medicine, Durham, United States.

Funding

Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI Nii A Addy · 2018 to 2026
$41.6M
Impact of new tobacco product design and synthetic additives on use initiation and preference behaviorR01DA060884 · NIDA · DUKE UNIVERSITY · PI SVEN-ERIC JORDT · 2024 to 2026
$1.8M
NIDA NIH HHS R01 DA060884NIDA NIH HHS U54 DA036151
6 · The paper itself

Abstract

Since late 2022, the sale of most flavored tobacco products has been prohibited in California, including menthol cigarettes. Tobacco companies responded by introducing 'non-menthol' cigarettes in which menthol was replaced with WS-3, an odorless synthetic cooling agent to elicit cooling sensations similar to menthol. Legislation enacted in 2024 banned the addition of cooling characterizing flavors in tobacco products in California. However, the industry continues to market 'non-menthol' cigarettes in the state, with very similar package designs. The aim of this study was to verify whether cooling agents were removed from these cigarettes. Available Newport-branded 'non-menthol' cigarettes were purchased in California in 2025, extracted and tested for sensory cooling activity by Ca

Indexed as

characterizing flavorscooling agentsmenthol cigarettesregulationWS-3

Identifiers

PMID42211562
PMCPMC13215131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.